HealthEquity, Inc. $HQY Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 54.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,615 shares of the company's stock after purchasing an additional 15,434 shares during the period. Hsbc Holdings PLC owned about 0.05% of HealthEquity worth $3,917,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at about $27,000. Caitong International Asset Management Co. Ltd increased its stake in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock worth $28,000 after buying an additional 293 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $28,000. Leonteq Securities AG raised its holdings in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC purchased a new position in HealthEquity in the first quarter worth approximately $33,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 2.0%

Shares of NASDAQ:HQY opened at $94.55 on Friday. The firm has a 50 day simple moving average of $99.58 and a 200-day simple moving average of $89.18. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $107.62. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $7.82 billion, a PE ratio of 34.13, a P/E/G ratio of 1.46 and a beta of 0.22.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The firm had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. The firm's revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Analyst Ratings Changes

HQY has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a research report on Monday, August 31st. Weiss Ratings reiterated a "hold (c+)" rating on shares of HealthEquity in a research note on Wednesday, September 2nd. Telsey Advisory Group set a $111.00 price target on HealthEquity in a research note on Friday, August 28th. Citigroup restated a "market outperform" rating on shares of HealthEquity in a research note on Friday, August 28th. Finally, Wall Street Zen downgraded HealthEquity from a "buy" rating to a "hold" rating in a report on Saturday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $111.87.

Insider Transactions at HealthEquity

In related news, Director Adrian T. Dillon sold 7,632 shares of the firm's stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director owned 62,395 shares in the company, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,354 shares of HealthEquity stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the transaction, the executive vice president directly owned 52,244 shares in the company, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,456 shares of company stock worth $1,256,664 in the last quarter. Insiders own 1.60% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.